ANDRE-JACQUES AUBERTON-HERVE Transaction History

Date Transaction Value Shares Traded Form
Jun 13 2023
BUY
Conversion of derivative security
$111,666 $0.6 p/Share
186,111
Jun 09 2023
BUY
Open market or private purchase
$390,000 $0.6 p/Share
650,000
Jul 15 2021
BUY
Exercise of conversion of derivative security
$200,698 $3.38 p/Share
59,378

Also insider at

CLAYU
Chavant Capital Acquisition Corp. Financial Services
AA

Andre Jacques Auberton Herve

Director
Toronto, A6

Track Institutional and Insider Activities on BNKL

Follow Bionik Laboratories Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BNKL shares.

Notify only if

Insider Trading

Get notified when an Bionik Laboratories Corp. insider buys or sells BNKL shares.

Notify only if

News

Receive news related to Bionik Laboratories Corp.

Track Activities on BNKL